Readers like you keep news free for everyone.
More than 5,000 readers have already pitched in to keep free access to The Journal.
For the price of one cup of coffee each week you can help keep paywalls away.
AP Photo/Ted Richardson
Robert Lefkowitz hugs his administrative assistant of 35 years Donna Addison in his office after hearing that he had won.
# Nobel Prize
US pair share chemistry Nobel for cell receptors
“I was fast asleep and the phone rang… my wife gave me an elbow – and there it was. A total shock and surprise,” said Robert Lefkowitz.
TWO SCIENTISTS, ROBERT Lefkowitz and Brian Kobilka of the United States, won the Nobel Prize for Chemistry today for identifying a class of cell receptor, yielding vital insights into how the body works at the molecular level.
The big beneficiary of this fundamental work is medicine, the Nobel committee declared.
The pair were honoured for discovering a key component of cells called G-protein-coupled receptors and mapping how they work.
The receptors stud the surface of cells, sensitising them to light, flavour, smells and body chemicals such as adrenaline and enabling cells to communicate with each other.
About a thousand of these kinds of receptor are known to exist throughout the body. They are essential not just for physiological processes but also for response to drugs.
“About half of all medications achieve their effect through G-protein-coupled receptors,” the Nobel jury said.
Understanding the receptors provides the tools for “better drugs with fewer side effects,” Nobel committee member Sven Lidin said.
G-protein-coupled receptors (GPCRs) are known to influence everything from sight, smell and taste to blood pressure, pain tolerance and metabolism.
They tell the inside of cells about conditions on the outside of their protective plasma membranes, to which the cells can form a response — communicating with each other and with the surrounding environment.
This explains how cardiac cells know to raise the heart rate when we are startled, for example.
Up to half the drugs that exist today aim at these tiny protein receptors, as they play a major role in influencing conditions ranging from allergies to depression and Parkinson’s disease.
They are targeted by everything from anti-histamines to ulcer drugs to beta blockers that relieve hypertension, angina and coronary disease.
How they found out
Robert Lefkowitz arrives at his office at Duke this morning. (AP Photo/Ted Richardson)
Lefkowitz, 69, is a professor of biomedicine and biochemistry at Duke University in North Carolina, while Kobilka, born in 1955, is a professor of molecular and cellular physiology at Stanford University School of Medicine in California.
In a teleconference with Swedish journalists, Lefkowitz admitted he had not heard the phone ring with the famous piece of news.
“I was fast asleep and the phone rang. I did not hear it. I must share with you that I wear ear plugs to sleep, and so my wife gave me an elbow: ‘phone for you.’ And there it was. A total shock and surprise,” he said.
Kobilka told Swedish news agency TT he was also awakened in the middle of the night at his home in California.
Asked if he would be able to fall back to sleep, he replied: “I don’t think so.”
“I’m still very surprised, they called me just an half hour ago, but now it is starting to slowly sink in,” he said.
Kobilka said he had not yet decided what he would do with his half of the€930,000 prize.
Background
The grandchild of Polish immigrants to the United States, Lefkowitz grew up as an only child in a two-bedroom apartment in New York’s Bronx.
He went to medical school at New York’s Columbia University, where he finished first in his class.
Kobilka was born in Little Falls, a small rural community in central Minnesota, where his grandfather and father were bakers and his mother decorated the cakes.
He studied biology and chemistry at the University of Minnesota in Duluth, and then went to Yale to study medicine.
In 1984, he went to Duke University, where he worked as a post-doctoral researcher under Lefkowitz. Together they put together the first genetic sequence of GPCRs.
The laureates will receive their prizes at formal ceremonies in Stockholm and Oslo on December 10, the anniversary of prize founder Alfred Nobel’s death in 1896.
